AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mader, I.
Right arrow Articles by Steinbrich, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mader, I.
Right arrow Articles by Steinbrich, W.

Serial Proton MR Spectroscopy of Contrast-enhancing Multiple Sclerosis Plaques: Absolute Metabolic Values over 2 Years during a Clinical Pharmacological Study

Irina MaderGo,a, Werner Rosera, Ludwig Kapposa, Gisela Hagberga, Joachim Seeliga, Ernst W. Raduea and Wolfgang Steinbricha

a From the Department of Neuroradiology, University Hospital, Tübingen, Germany (I.M.); the Departments of Neuroradiology (I.M., W.R., E.W.R., W.S.) and Neurology (L.K.), University Hospital, Basel, Switzerland; the MR-Center and Biocenter, University of Basel, Basel, Switzerland (W.R., G.H., J.S.).



View larger version (128K):

[in a new window]
 
FIG 1. A and B, Two representative sections, one showing an acute MS plaque on a contrast-enhanced T1-weighted image (A) and another indicating the position of the VOI superimposed on a T2-weighted image (B)



View larger version (21K):

[in a new window]
 
FIG 2. Series of STEAM spectra (TE = 20) of an initially contrast-enhancing plaque over a period of 2 years (TR = 3000, mixing time = 30 milliseconds). No baseline correction has been applied. The indicated resonances are NAA, Cr, Cho, and myo-inositol (m-Ino). Cho shows a clear reduction at month 3; Cr shows an elevation in month 12



View larger version (42K):

[in a new window]
 
FIG 3. The absolute concentrations of the metabolites as a function of time. The mean of the healthy control subjects ± 1 SEM is indicated by the horizontal bars.

A, Time course of NAA. After a reduction in month 1, a slow recovery is visible until month 22.

B, Time course of Cr. There is a significant elevation from month 3 to months 6 and 12.

C, Time course of Cho. Note the significant decrease from month 0 to month 3.

D, Time course of myo-inositol. No systematic changes are recognizable.



View larger version (10K):

[in a new window]
 
FIG 4. Absolute concentration of metabolites as a function of plaque size.

A, The concentration of NAA (in mM/L) correlated with total plaque volume on T2-weighted images, expressed as a percentage of the VOI (in %). There is a negative correlation between NAA and total plaque volume on T2-weighted images (r = -0.26, P < .05).

B, The concentration of NAA (in mM/L) correlated with chronic plaque volume on T2-weighted images, expressed as a percentage of the VOI (in %). There is a stronger negative correlation between NAA and chronic plaque volume on T2-weighted images than in A (r = -0.38, P < .01).

C, The concentration of Cr (in mM/L) correlated with the volume of acute contrast-enhancing plaques on T1-weighted images, expressed as a percentage of the VOI (in %). Note the negative correlation between Cr and acute contrast-enhancing plaque volume on T1-weighted images (r = -0.9, P < .03).